Suscribirse

A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)–Prevenzione scoring - 17/08/11

Doi : 10.1016/j.ahj.2005.10.023 
Alejandro Macchia, MD a, Giacomo Levantesi, MD a, Giovanna Borrelli, MSc a, Maria Grazia Franzosi, MSc c, Aldo Pietro Maggioni, MD b, RosaMaria Marfisi, MS a, Marco Scarano, MSc a, Luigi Tavazzi, MD d, Gianni Tognoni, MD a, Franco Valagussa, MD e, Roberto Marchioli, MD a, ⁎
a Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy 
b Centro Studi ANMCO, Firenze, Italy 
c Department of Cardiovascular Disease, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy 
d IRCCS Policlinico San Matteo, Pavia, Italy 
e Ospedale San Gerardo, Monza, Italy 

⁎Reprint requests: Roberto Marchioli, MD, Department of Clinical Pharmacology and Epidemiology, Laboratory of Clinical Epidemiology of Cardiovascular Disease, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy.

on behalf of Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)–Prevenzione Investigatorsf

  The names of GISSI-Prevenzione Investigators are reported in reference.21
Associazione Nazionale Medici Cardiologi Ospedalieri, Italy, Istituto di Ricerche Farmacologiche Mario Negri-Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy


Resumen

Background

Metabolic syndrome (MS) is associated with late-onset diabetes. However, diagnostic criteria for individual components of MS are based on categorical/arbitrary cut points and, therefore, do not exploit the information yield of each factor. We aimed to generate a diagnostic score for MS (MS-Score), aimed at predicting diabetes by giving appropriate weight to the individual components of MS.

Methods

Of 11323 patients with prior myocardial infarction and followed up for 3.5 years in the GISSI-Prevenzione study, 3855 subjects with diabetes at baseline or missing information for relevant variables were excluded. A Cox proportional hazards model including age, sex, glycemia, high-density lipoprotein cholesterol, triglycerides, hypertension, and body mass index was fitted to create a diagnostic score. A cutoff point of 28 of the score was the best compromise between sensitivity and specificity for MS diagnosis (MS-Score). The prognostic performance of the MS-Score was compared with that of the diagnostic criteria of MS, as defined by National Cholesterol Education Program Adult Treatment Panel III (MS-ATP).

Results

Of 7468 patients, 940 developed diabetes. The risk of getting diabetes significantly and progressively increased in the quintiles of the score reaching >6-fold higher risk in the last one. The predictive capability of MS-Score was significantly higher than that of the MS-ATP (AUC = 0.650 vs 0.587, sensitivity 67% vs 52%, specificity 63% vs 66%, P = .0002). The MS-Score, but not the MS-ATP, was significantly associated with mortality.

Conclusion

MS-Score improves the prediction of diabetes development by using the full informative content of individual components for diagnosis of MS.

El texto completo de este artículo está disponible en PDF.

Esquema


© 2006  Mosby, Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 151 - N° 3

P. 754.e7-754.e17 - mars 2006 Regresar al número
Artículo precedente Artículo precedente
  • The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers
  • David A. Gorelick, Stephen J. Heishman, Kenzie L. Preston, Richard A. Nelson, Eric T. Moolchan, Marilyn A. Huestis
| Artículo siguiente Artículo siguiente
  • The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events
  • Carol E. Koro, Steven J. Bowlin, Timothy E. Stump, Dennis L. Sprecher, William M. Tierney

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.